论文部分内容阅读
目的 观察降纤酶治疗急性脑梗死疗效。 方法 将病例随机分为 :试验组 30例 ,应用降纤酶 1 0 u、5u、 5u各加生理盐水 1 0 0 ml静脉滴注 ,隔天 1次 ,共 3次 ,治疗前后监测纤维蛋白原 (FG) ;对照组 1 5例 ,用东菱克栓酶其剂量及用法与试验组相同。同时两组应用 70 6代血浆等药物治疗。 结果 试验组基本痊愈 34 .97% ,显著进步 55.0 3% ,进步 4 % ,无变化 3% ,无恶化、死亡病例 ,总有效率达 93.97% ,无出血病例。对照组基本治愈 55.55% ,显著进步 2 5.0 % ,总有效率 80 .55%。两组比较无明显差异。试验组 FG在用药前后有明显差异。结论 降纤酶治疗急性脑梗死是安全、有效的
Objective To observe the curative effect of defibrase on acute cerebral infarction. Methods The cases were randomly divided into: experimental group of 30 cases, the use of defibrase 10 u, 5u, 5u plus saline 100 ml intravenous infusion, once every other day, a total of 3 times before and after treatment to detect fibrinogen (FG). In the control group, 15 cases were treated with the same dosage and usage of batroxobin. At the same time two groups of 70 6 generations of plasma and other drug treatment. Results The experimental group basically cured 34.97%, significantly improved 55.0 3%, improved 4%, no change 3%, no deterioration, deaths, the total effective rate 93.97%, no bleeding cases. The control group basically cured 55.55%, significant progress 5.05%, the total effective rate 80.55%. No significant difference between the two groups. Test group FG before and after treatment were significantly different. Conclusion Defibrase in the treatment of acute cerebral infarction is safe and effective